Yoon-La Choi

Author PubWeight™ 94.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One 2009 4.62
2 Early osteolysis following second-generation metal-on-metal hip replacement. J Bone Joint Surg Am 2005 1.89
3 Identification of novel reference genes using multiplatform expression data and their validation for quantitative gene expression analysis. PLoS One 2009 1.55
4 Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ. Cell Rep 2013 1.44
5 Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients. J Clin Oncol 2013 1.40
6 Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer. PLoS Genet 2008 1.39
7 Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression. Clin Cancer Res 2007 1.35
8 Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapy. BMC Cancer 2009 1.31
9 Impact of KRAS mutations on clinical outcomes in pancreatic cancer patients treated with first-line gemcitabine-based chemotherapy. Mol Cancer Ther 2011 1.31
10 High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients. Histol Histopathol 2012 1.26
11 A dramatic response to crizotinib in a non-small-cell lung cancer patient with IHC-positive and FISH-negative ALK. J Thorac Oncol 2012 1.23
12 Expression of caveolin-1 is associated with poor prognosis of patients with squamous cell carcinoma of the lung. Lung Cancer 2003 1.21
13 Prognostic value of 18F-FDG PET/CT in patients with soft tissue sarcoma: comparisons between metabolic parameters. Skeletal Radiol 2014 1.20
14 BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAFV600E-prevalent population. J Clin Endocrinol Metab 2010 1.13
15 Cancer-associated splicing variant of tumor suppressor AIMP2/p38: pathological implication in tumorigenesis. PLoS Genet 2011 1.12
16 The diagnostic utility of the GNAS mutation in patients with fibrous dysplasia: meta-analysis of 168 sporadic cases. Hum Pathol 2012 1.12
17 AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration. Exp Mol Med 2011 1.08
18 Clinical implications of T790M mutation in patients with acquired resistance to EGFR tyrosine kinase inhibitors. Lung Cancer 2013 1.06
19 Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker. PLoS One 2011 1.03
20 Multiplexed gene expression and fusion transcript analysis to detect ALK fusions in lung cancer. J Mol Diagn 2012 1.03
21 Operative treatment of primary synovial osteochondromatosis of the hip. J Bone Joint Surg Am 2006 1.02
22 Pure ground-glass opacity neoplastic lung nodules: histopathology, imaging, and management. AJR Am J Roentgenol 2014 0.98
23 Repeat biopsy for mutational analysis of non-small cell lung cancers resistant to previous chemotherapy: adequacy and complications. Radiology 2012 0.97
24 Frequency of KRAS, BRAF, and PIK3CA mutations in advanced colorectal cancers: Comparison of peptide nucleic acid-mediated PCR clamping and direct sequencing in formalin-fixed, paraffin-embedded tissue. Pathol Res Pract 2011 0.97
25 Centrosomal PKCbetaII and pericentrin are critical for human prostate cancer growth and angiogenesis. Cancer Res 2008 0.96
26 Claudin-4 overexpression is associated with epigenetic derepression in gastric carcinoma. Lab Invest 2011 0.96
27 Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications. Carcinogenesis 2010 0.95
28 Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: relation to response patterns on MRI. Acta Oncol 2007 0.94
29 Genomic copy number alterations associated with the early brain metastasis of non-small cell lung cancer. Int J Oncol 2012 0.93
30 The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells. Breast Cancer Res 2014 0.93
31 Atypical leiomyomas of the uterus with long-term follow-up after myomectomy with immunohistochemical analysis for p16INK4A, p53, Ki-67, estrogen receptors, and progesterone receptors. Int J Gynecol Pathol 2009 0.93
32 MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer. Int J Cancer 2014 0.92
33 Increased expression of sonic hedgehog and altered methylation of its promoter region in gastric cancer and its related lesions. Mod Pathol 2006 0.91
34 Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle. Prostate 2008 0.91
35 Engagement of CD99 triggers the exocytic transport of ganglioside GM1 and the reorganization of actin cytoskeleton. FEBS Lett 2003 0.90
36 Sclerosing epithelioid fibrosarcoma: cytogenetic analysis of FUS rearrangement. Pathol Int 2011 0.89
37 Enhanced expression of hedgehog signaling molecules in squamous cell carcinoma of uterine cervix and its precursor lesions. Mod Pathol 2006 0.89
38 The different efficacy of gefitinib or erlotinib according to epidermal growth factor receptor exon 19 and exon 21 mutations in Korean non-small cell lung cancer patients. J Cancer Res Clin Oncol 2010 0.89
39 T cell expression of CIITA represses Th1 immunity. Int Immunol 2004 0.89
40 Development and characterization of a bladder cancer xenograft model using patient-derived tumor tissue. Cancer Sci 2013 0.89
41 MET expression in sporadic renal cell carcinomas. J Korean Med Sci 2006 0.89
42 Angiosarcoma arising within a long-standing cystic lesion of the adrenal gland: a case report. J Clin Oncol 2013 0.88
43 HIP1-ALK, a novel fusion protein identified in lung adenocarcinoma. J Thorac Oncol 2014 0.88
44 Clinicopathological study of seven cases of symptomatic supratentorial subependymoma. J Neurooncol 2003 0.87
45 Epidermal growth factor receptor mutation and treatment outcome of mediastinoscopic N2 positive non-small cell lung cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery. Lung Cancer 2012 0.87
46 Integrative analysis of copy number alteration and gene expression profiling in ovarian clear cell adenocarcinoma. Cancer Genet 2013 0.87
47 Clinical significance of CD99 down-regulation in gastric adenocarcinoma. Clin Cancer Res 2007 0.86
48 A potential case of intraductal tubulopapillary neoplasms of the bile duct. Pathol Int 2010 0.86
49 Synovial sarcoma of the spine: a case involving paraspinal muscle with extensive calcification and the surgical consideration in treatment. Eur Spine J 2014 0.86
50 CC chemokine ligand 7 expression in liver metastasis of colorectal cancer. Oncol Rep 2012 0.85
51 Correlation between tumor volume response to radiotherapy and expression of biological markers in patients with cervical squamous cell carcinoma. J Gynecol Oncol 2009 0.85
52 Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization. Pathol Int 2008 0.85
53 Extensive alteration in the expression profiles of TGFB pathway signaling components and TP53 is observed along the gastric dysplasia-carcinoma sequence. Histol Histopathol 2008 0.85
54 Comparison of Three BRAF Mutation Tests in Formalin-Fixed Paraffin Embedded Clinical Samples. Korean J Pathol 2013 0.85
55 Assessment of intratumoral heterogeneity of oncogenic driver mutations in surgically-resected lung adenocarcinoma: implications of percutaneous biopsy-based molecular assay for target-directed therapy. Anticancer Res 2014 0.84
56 The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo. Int J Cancer 2011 0.84
57 Ovarian perivascular epithelioid cell tumor not otherwise specified with transcription factor E3 gene rearrangement: a case report and review of the literature. Hum Pathol 2012 0.84
58 Identification of signal peptide domain SOST mutations in autosomal dominant craniodiaphyseal dysplasia. Hum Genet 2011 0.84
59 A prognostic model for lymph node-negative breast cancer patients based on the integration of proliferation and immunity. Breast Cancer Res Treat 2011 0.83
60 Extranodal follicular dendritic cell sarcoma with rapid growth in parapharynx: a case report. Korean J Pathol 2012 0.83
61 High expression of tissue inhibitor of metalloproteinase-2 in serous ovarian carcinomas and the role of this expression in ovarian tumorigenesis. Hum Pathol 2006 0.83
62 Merkel cell carcinoma: our experience with seven patients in Korea and a literature review. J Plast Reconstr Aesthet Surg 2010 0.83
63 Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitors. Cancer 2010 0.83
64 Mutated IDH1 is a favorable prognostic factor for type 2 gliomatosis cerebri. Brain Pathol 2011 0.83
65 Low SP1 expression differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma. PLoS One 2013 0.83
66 Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach. Medicine (Baltimore) 2015 0.83
67 Tob1 induces apoptosis and inhibits proliferation, migration and invasion of gastric cancer cells by activating Smad4 and inhibiting β‑catenin signaling. Int J Oncol 2012 0.83
68 Low frequency of KRAS mutation in pancreatic ductal adenocarcinomas in Korean patients and its prognostic value. Pancreas 2015 0.83
69 Expression of sonic hedgehog signaling molecules in normal, hyperplastic and carcinomatous endometrium. Pathol Int 2009 0.82
70 Characterization and epitope mapping of two monoclonal antibodies against human CD99. Exp Mol Med 2002 0.82
71 Peripheral primitive neuroectodermal tumor with osseous component of the small bowel mesentery: a case study. Korean J Pathol 2013 0.82
72 The neurological safety of epidural gabapentin in rats: a light microscopic examination. Anesth Analg 2005 0.82
73 Prognostic significance of CD151 overexpression in non-small cell lung cancer. Lung Cancer 2013 0.82
74 Expression of CD44 adhesion molecules on human placentae. Eur J Obstet Gynecol Reprod Biol 2006 0.82
75 Primary central nervous system lymphoma in Korea: comparison of B- and T-cell lymphomas. Am J Surg Pathol 2003 0.82
76 Prevalence of the CTNNB1 mutation genotype in surgically resected fibromatosis of the breast. Histopathology 2012 0.81
77 Conization using electrosurgical conization and cold coagulation for international federation of gynecology and obstetrics stage IA1 squamous cell carcinomas of the uterine cervix. Int J Gynecol Cancer 2009 0.81
78 The neurotoxicity of epidural hyaluronic acid in rabbits: a light and electron microscopic examination. Anesth Analg 2003 0.81
79 Identification of prognostic biomarkers for glioblastomas using protein expression profiling. Int J Oncol 2011 0.81
80 Comparison of Her-2, EGFR and cyclin D1 in primary breast cancer and paired metastatic lymph nodes: an immunohistochemical and chromogenic in situ hybridization study. J Korean Med Sci 2008 0.81
81 CIP2A expression is associated with synovial hyperplasia and invasive function of fibroblast-like synoviocytes in rheumatoid arthritis. Rheumatol Int 2011 0.81
82 Efficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma NSCLC patients with EGFR mutation. Cancer Chemother Pharmacol 2012 0.81
83 Favorable clinical outcomes of pemetrexed treatment in anaplastic lymphoma kinase positive non-small-cell lung cancer. Lung Cancer 2012 0.80
84 Expression of MET in alveolar soft part sarcoma. Med Oncol 2009 0.80
85 Increased expression of calpain 6 during the progression of uterine cervical neoplasia: immunohistochemical analysis. Oncol Rep 2008 0.80
86 FOXL2 mutation in granulosa-cell tumours of the ovary. Histopathology 2010 0.79
87 Levodopa-induced dyskinesia in an autopsy-proven case of progressive supranuclear palsy. Mov Disord 2002 0.79
88 Epithelioid hemangioendothelioma with extensive cystic change and CAMTA1 rearrangement. Pathol Int 2013 0.79
89 Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium. Histol Histopathol 2009 0.79
90 Surgical outcome of desmoid tumors: adjuvant radiotherapy delayed the recurrence, but did not affect long-term outcomes. J Surg Oncol 2013 0.79
91 Real world impact of epidermal growth factor receptor mutation status on treatment patterns in patients with non-small cell lung cancer. Lung Cancer 2013 0.78
92 Prognostic significance of CD24 protein expression in patients treated with adjuvant radiotherapy after radical hysterectomy for cervical squamous cell carcinoma. Radiother Oncol 2010 0.77
93 MHC class II engagement inhibits CD99-induced apoptosis and up-regulation of T cell receptor and MHC molecules in human thymocytes and T cell line. FEBS Lett 2003 0.77
94 Low expression of transforming growth factor beta-1 in cancer tissue predicts a poor prognosis for patients with stage III rectal cancers. Oncology 2014 0.77
95 Oncogenic anaplastic lymphoma kinase (ALK) mutation in neuroblastomas and other pediatric tumors. Pathol Res Pract 2011 0.76
96 Diagnostic Value of MDM2 and DDIT3 Fluorescence In Situ Hybridization in Liposarcoma Classification: A Single-Institution Experience. Korean J Pathol 2012 0.76
97 Establishment of primary xenograft model from newly characterized patient extrauterine carcinosarcoma. Int J Gynecol Cancer 2013 0.76
98 Tissue expander placement and adjuvant radiotherapy after surgical resection of retroperitoneal liposarcoma offers improved local control. Medicine (Baltimore) 2016 0.75
99 The effect of cyclooxygenase-2 expression on tumor volume response in patients treated with radiotherapy for uterine cervical cancer. J Korean Med Sci 2009 0.75
100 Prognostic implications of tumor volume response and COX-2 expression change during radiotherapy in cervical cancer patients. Radiat Oncol J 2012 0.75
101 Triple Gene Analysis Using Samples Obtained by Endobronchial Ultrasound-guided Transbronchial Needle Aspiration. Intern Med 2016 0.75
102 Role of imaging biomarkers in predicting anaplastic lymphoma kinase-positive lung adenocarcinoma. Clin Nucl Med 2015 0.75
103 New 3-Tiered Circumferential Resection Margin Criteria in Esophageal Squamous Cell Carcinoma. Ann Surg 2015 0.75
104 Identification of a cut-off for the MACIS score to predict the prognosis of differentiated thyroid carcinoma in children and young adults. Head Neck 2011 0.75
105 Tissue expander placement and adjuvant radiotherapy after surgical resection of retroperitoneal liposarcoma offers improved local control. Medicine (Baltimore) 2016 0.75
106 Detection of germinal center B-cell lymphoma in archival specimens: critical evaluation of Bcl-6 protein expression in diffuse large B-cell lymphoma of the tonsil. Hum Pathol 2003 0.75
107 PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications. Hum Pathol 2013 0.75
108 Correlation of quantitative dynamic contrast-enhanced MRI with microvascular density in necrotic, partial necrotic, and viable liver tumors in a rabbit model. J Appl Clin Med Phys 2016 0.75
109 Intraductal thermal injury using a heat probe and radiofrequency ablation electrode in a swine model of biliary stenosis. Clin Res Hepatol Gastroenterol 2012 0.75
110 Presence of anaplastic lymphoma kinase translocation in sarcomatoid carcinoma of head and neck and treatment effect of crizotinib: A case series. Head Neck 2015 0.75
111 The neurological safety of intrathecal acyclovir in rats. Pain Physician 2012 0.75
112 Mutations of the immunoglobulin heavy chain variable region gene in CD99-deficient BJAB cell line. Mol Cells 2002 0.75
113 Single-center experience with intra-abdominal liposarcoma: Optimal minimum duration for postoperative remnant tumor screening. Medicine (Baltimore) 2017 0.75
114 Dermatofibrosarcoma protuberans of the breast skin. Pathol Int 2010 0.75
115 Small node-negative (T1b-cN0) invasive hormone receptor-positive breast cancers: is there a subpopulation that might have benefit from adjuvant chemotherapy? Breast Cancer Res Treat 2012 0.75